A formal test for interaction confirmed a significant difference in the relationship between copeptin and risk of stroke and CVD between men with and without diabetes after the exclusion of men with MI or stroke (p = 0.01 and p = 0.02, respectively). The gene discussed is AVP; the disease is diabetes mellitus.